Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]
A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]
Moderna Inc. (Nasdaq: MRNA), the developer of the messenger RNA-based vaccine candidate known as mRNA-1273, reports that the independent NIH […]
The University of Illinois’ Health System launches the COVID-19 vaccine trial testing Moderna’s mRNA-1273 starting this Monday. Led by University […]
Last week Moderna announced that the U.S. government secured 100 million doses of its COVID-19 vaccine candidate known as mRNA-1273 […]
At the onset of the COVID-19 pandemic, the national research apparatus rapidly responded, mobilizing a powerful clinical trial site network […]
By September 2018, Javara and Wake Forest Baptist Health announced their intention to deliver the clinical research as a care option […]
Hattiesburg Clinic in Hattiesburg, Mississippi, was selected by Moderna as one of the 89 clinical investigational site for the pivotal […]
Kelli Benedetti, one of the first of eight participants to join the Moderna phase 3 COVID-19 vaccine trial at Benchmark […]
Hope Research Institute in Phoenix, Arizona, part of the “Valley of the Sun” region was selected by Moderna for its Phase […]
